Published in Pacing Clin Electrophysiol on March 01, 1992
Dual chamber pacing: how many patients remain in DDD mode over the long term? Br Heart J (1995) 1.25
Impact of continuous quality improvement on selection of pacing mode and rate of complications in permanent pacing. Heart (1997) 0.91
The United Kingdom pacing and cardiovascular events (UKPACE) trial. United Kingdom Pacing and Cardiovascular Events. Heart (1997) 0.85
Predictors of loss of atrioventricular synchrony in single lead VDD pacing. Heart (1998) 0.79
Pacing mode and long-term survival in elderly patients with congestive heart failure: 1980-1985. J Interv Card Electrophysiol (1997) 0.77
Cardiac pacing for bradyarrhythmias in the elderly. J R Soc Med (1994) 0.75
Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J (2005) 5.40
Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial. Lancet (1981) 4.75
Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol (1995) 4.50
Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) N Engl J Med (1992) 3.87
[Acute coronary syndromes. Simplified routines with early exercise test performed at the intensive coronary care units]. Lakartidningen (1993) 3.19
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation (1999) 3.06
Serum sialic acid concentration and cardiovascular mortality. BMJ (1991) 2.96
Low serum cholesterol concentration and short term mortality from injuries in men and women. BMJ (1992) 2.94
Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J (2004) 2.80
The Malmö Diet and Cancer Study: representativity, cancer incidence and mortality in participants and non-participants. Eur J Cancer Prev (2001) 2.72
The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation. Eur Heart J (2000) 2.56
Dusty starburst galaxies in the early Universe as revealed by gravitational lensing. Nature (2013) 2.35
A comparison of the acute and long-term hemodynamic effects of ventricular inhibited and atrial synchronous ventricular inhibited pacing. Circulation (1982) 2.22
Lipoprotein(a) as a determinant of coronary heart disease in young women. Circulation (1997) 2.13
Atrial versus ventricular pacing in sinus node disease: a treatment comparison study. Am Heart J (1986) 2.05
The role of AIB1 and PAX2 in primary breast cancer: validation of AIB1 as a negative prognostic factor. Ann Oncol (2012) 2.02
Completion axillary dissection can safely be omitted in screen detected breast cancer patients with micrometastases. A decade's experience from a single institution. Eur J Surg Oncol (2013) 1.99
Screening mammography. Lancet (1991) 1.94
Estimation of liver tumor volume using different formulas - an experimental study in rats. J Cancer Res Clin Oncol (1983) 1.91
Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Diabetes Insulin-Glucose in Acute Myocardial Infarction. Eur Heart J (1996) 1.83
The apparent incidence of hip fracture in Europe: a study of national register sources. Osteoporos Int (1992) 1.81
Risk factors for hip fracture in European women: the MEDOS Study. Mediterranean Osteoporosis Study. J Bone Miner Res (1995) 1.79
Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. PIC Study Group. Eur Heart J (1997) 1.76
Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care (1999) 1.72
Sociodemographic factors associated with long-term weight gain, current body fatness and central adiposity in Swedish women. Int J Obes Relat Metab Disord (2000) 1.72
Cost-effectiveness of intense insulin treatment after acute myocardial infarction in patients with diabetes mellitus; results from the DIGAMI study. Eur Heart J (2000) 1.60
Risk factors for hip fracture in men from southern Europe: the MEDOS study. Mediterranean Osteoporosis Study. Osteoporos Int (1999) 1.59
Quality of life in octogenarians after valve replacement due to aortic stenosis. A prospective comparison with younger patients. Eur Heart J (1996) 1.56
Difference in mortality between patients treated with captopril or enalapril in the Xamoterol in Severe Heart Failure Study. Am J Cardiol (1991) 1.52
Food patterns and components of the metabolic syndrome in men and women: a cross-sectional study within the Malmö Diet and Cancer cohort. Am J Epidemiol (2001) 1.51
Asymptomatic versus symptomatic persistent atrial fibrillation: clinical and noninvasive characteristics. J Intern Med (2001) 1.49
Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves. J Am Coll Cardiol (1994) 1.46
The variable incidence of hip fracture in southern Europe: the MEDOS Study. Osteoporos Int (1994) 1.46
Control of blood pressure and risk of first acute myocardial infarction: Skaraborg hypertension project. BMJ (1994) 1.46
Social relations and extent and severity of coronary artery disease. The Stockholm Female Coronary Risk Study. Eur Heart J (1998) 1.45
Beta cell dysfunction in patients with acute myocardial infarction but without previously known type 2 diabetes: a report from the GAMI study. Diabetologia (2005) 1.44
Continuous ambulatory haemodynamic monitoring with an implantable system. The feasibility of a new technique. Eur Heart J (1998) 1.44
Continuous haemodynamic monitoring during withdrawal of diuretics in patients with congestive heart failure. Eur Heart J (2002) 1.42
Phenformin and pulmonary hypertension. Br Heart J (1973) 1.40
Cardiac outflow of endothelin, neuropeptide Y and noradrenaline in relation to hyperaemia in coronary sinus flow following electrical conversion of induced ventricular fibrillation in man. Eur Heart J (1995) 1.40
Brief episodes of ventricular fibrillation do not influence postischemic cerebral perfusion assessed by positron emission tomography. Crit Care Med (1997) 1.39
A new apparatus for detection of impending pacemaker failure in patients treated with implanted pacemakers. Cardiovasc Res (1970) 1.39
Effects of long-term right ventricular apical pacing on left ventricular perfusion, innervation, function and histology. J Am Coll Cardiol (1994) 1.37
Preparation and properties of the major copper-binding component in human fetal liver. Its identification as metallothionein. J Biol Chem (1978) 1.37
Monitoring of mixed venous oxygen saturation and pressure from biosensors in the right ventricle. A 24 hour study in patients with heart failure. Eur Heart J (1995) 1.37
Reinvestigation of some physicochemical and chemical properties of human ceruloplasmin (ferroxidase). Biochemistry (1976) 1.36
Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients. Br J Cancer (2004) 1.36
A rapid and specific method for isolation of thiol-containing peptides from large proteins by thiol-disulfide exchange on a solid support. Proc Natl Acad Sci U S A (1975) 1.33
Joint efforts across national boundaries between professional organizations in cardiovascular medicine: one way into the future. Eur Heart J (2000) 1.31
Re-used pacemakers--as safe as new? A retrospective case-control study. Eur Heart J (1998) 1.31
Myocardial infarction in patients with diabetes mellitus. Eur Heart J (1988) 1.30
Two-year results of a controlled study of residential rehabilitation for patients treated with percutaneous transluminal coronary angioplasty. A randomized study of a multifactorial programme. Eur Heart J (1999) 1.28
Haemorrhagic and thromboembolic complications in patients with atrial fibrillation on anticoagulant prophylaxis. J Intern Med (1989) 1.26
Mode of death in heart failure: findings from the ATLAS trial. Heart (2003) 1.24
Improved physical fitness and quality of life following training of elderly patients after acute coronary events. A 1 year follow-up randomized controlled study. Eur Heart J (1999) 1.23
The Malmö Food Study: validity of two dietary assessment methods for measuring nutrient intake. Int J Epidemiol (1997) 1.22
Quality-of-life in patients treated with atrioventricular synchronous pacing compared to rate modulated ventricular pacing: a long-term, double-blind, crossover study. Pacing Clin Electrophysiol (1992) 1.21
Serum sialic acid concentration and smoking: a population based study. BMJ (1991) 1.20
Predicting various fragility fractures in women by forearm bone densitometry: a follow-up study. Calcif Tissue Int (1993) 1.19
Aortic valve replacement in octogenarians with aortic stenosis: a case-control study. J Am Coll Cardiol (1992) 1.18
Physiological versus single-rate ventricular pacing: a double-blind cross-over study. Pacing Clin Electrophysiol (1985) 1.16
Chronic atrial fibrillation. Long-term results of direct current conversion. Acta Med Scand (1988) 1.15
Joint efforts across national boundaries between professional organizations in cardiovascular medicine: one way into the future. J Am Coll Cardiol (2000) 1.15
Breath concentration as an index of the health risk from benzene. Studies on the accumulation and clearance of inhaled benzene. Scand J Work Environ Health (1980) 1.15
Single-chain structure of human ceruloplasmin. Eur J Biochem (1972) 1.14
The effect of ventricular activation sequence on cardiac performance during pacing. Pacing Clin Electrophysiol (1996) 1.14
Comparison of physical work capacity and systolic time intervals with ventricular inhibited and atrial synchronous ventricular inhibited pacing. Br Heart J (1981) 1.14
Catheter ablation of the atrioventricular junction with radiofrequency energy. Circulation (1989) 1.14
Augmented metabolic control improves myocardial diastolic function and perfusion in patients with non-insulin dependent diabetes. Heart (2004) 1.12
Management of atrial fibrillation: discrepancy between guideline recommendations and actual practice exposes patients to risk for complications. Eur Heart J (2001) 1.12
Molecular weight of beef heart aconitase and stoichiometry of the components of its iron-sulfur cluster. J Biol Chem (1984) 1.12
Serum sialic acid concentration predicts both coronary heart disease and stroke mortality: multivariate analysis including 54,385 men and women during 20.5 years follow-up. Int J Epidemiol (1992) 1.12
Isolation and properties of a staphylococcal protease, preferentially cleaving glutamoyl-peptide bonds. Eur J Biochem (1974) 1.12
Risk of pelvic inflammatory disease among intrauterine-device users irrespective of previous pregnancy. Lancet (1980) 1.11
Factors predicting success rate and recurrence of atrial fibrillation after first electrical cardioversion in patients with persistent atrial fibrillation. Clin Cardiol (2001) 1.11
Causes of more frequent deletions than insertions in mutations and protein evolution. Nature (1981) 1.10
Tocainide kinetics after intravenous and oral administration in healthy subjects and in patients with acute myocardial infarction. Clin Pharmacol Ther (1980) 1.10
Association between fat intake, physical activity and mortality depending on genetic variation in FTO. Int J Obes (Lond) (2010) 1.10
Diabetes mellitus and congestive heart failure. Further knowledge needed. Eur Heart J (1999) 1.09
Long term experience of felodipine in combination with beta-blockade and diuretics in refractory hypertension. Drugs (1985) 1.08
The Malmö Food Study: the relative validity of a modified diet history method and an extensive food frequency questionnaire for measuring food intake. Eur J Clin Nutr (1996) 1.07
Myocardial injury after electrical therapy for cardiac arrhythmias assessed by troponin-T release. Am J Cardiol (1997) 1.07
Pathology parameters and adjuvant tamoxifen response in a randomised premenopausal breast cancer trial. J Clin Pathol (2005) 1.07
Serum concentrations of beta-carotene and alpha-tocopherol are associated with diet, smoking, and general and central adiposity. Am J Clin Nutr (2001) 1.07
A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias. N Engl J Med (1983) 1.06
The hospital burden of vertebral fracture in Europe: a study of national register sources. Osteoporos Int (1997) 1.06
Placebo effect of pacemaker implantation in obstructive hypertrophic cardiomyopathy. PIC Study Group. Pacing In Cardiomyopathy. Am J Cardiol (1999) 1.06
Spontaneous episodes of atrial fibrillation after implantation of the Metrix Atrioverter: observations on treated and nontreated episodes. Metrix Investigators. J Am Coll Cardiol (2000) 1.06
Circumstances around the fall in a multinational hip fracture risk study: a diverse pattern for prevention. MEDOS Study Group). Mediterranean Osteoporosis Study. Accid Anal Prev (1998) 1.05
Self-administered questionnaire compared with a personal diary for assessment of current use of hormone therapy: an analysis of 16,060 women. Am J Epidemiol (2000) 1.05
A new rating scale for dementia syndromes. Arch Gerontol Geriatr (1982) 1.05